HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

5-Hydroxytryptamine mediates the post-embolic increase in respiratory rate in anaesthetized rabbits.

Abstract
The effect of the neuronal 5-HT3 receptor antagonist MDL 72222 has been investigated on the reflex tachypnoeic response to pulmonary embolism in pentobarbitone-anaesthetized rabbits. Pre-treatment with MDL 72222 (640 micrograms kg-1, 5 min prior to embolization) significantly attenuated the reflex tachypnoeic response associated with the injection of emboli. MDL 72222 had no effect on the bradycardia associated with embolization; however, it significantly reduced the decrease in arterial blood pressure and converted the decrease in tidal volume seen in pulmonary embolism to an increase. Furthermore, MDL 72222 had no effect on the decrease in circulating platelet count associated with embolization. The data suggest that 5-hydroxytryptamine is of primary importance in mediating the post-embolic increase in respiratory rate seen in this model of pulmonary embolism.
AuthorsD J Armstrong, I S Kay
JournalExperimental physiology (Exp Physiol) Vol. 75 Issue 4 Pg. 475-81 (Jul 1990) ISSN: 0958-0670 [Print] England
PMID2223050 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Serotonin Antagonists
  • Tropanes
  • Serotonin
  • bemesetron
  • Indomethacin
Topics
  • Analysis of Variance
  • Animals
  • Blood Pressure (drug effects)
  • Heart Rate (drug effects)
  • Indomethacin (pharmacology)
  • Platelet Count (drug effects)
  • Pulmonary Embolism (physiopathology)
  • Rabbits
  • Respiration (physiology)
  • Serotonin (physiology)
  • Serotonin Antagonists
  • Tidal Volume (drug effects)
  • Tropanes

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: